Unique collaboration to build Nordic health industry
A new collaboration agreement between AstraZeneca, Oslo Cancer Cluster, and Oslo Science City aims to strengthen the Nordic health industry.
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 272 entries.
A new collaboration agreement between AstraZeneca, Oslo Cancer Cluster, and Oslo Science City aims to strengthen the Nordic health industry.
World-leading translational cancer research entered Oslo Cancer Cluster Innovation Park last week and created a buzz.
Meet the sponsors behind Cancer Crosslinks 2024: Bristol Myers Squibb and Daiichi-Sankyo.
Meet the members who recently joined or re-joined our cluster.